- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06341491
The Study of Delay Discounting Among Beneficiaries of the Pé-de-Meia Program
The Study of Delay Discounting Propensity Among Beneficiaries of the Pé-de-Meia Program: The High School Savings Plan
The aim of this observational study is to explore how the "Pé-de-Meia" Program, a policy of the Brazilian Federal Government designed to encourage the retention and completion of studies by students from low-income families, affects both the students' tendency towards delay discounting and their academic performance. The study seeks to answer the following questions:
How does the "Pé-de-Meia" Program affect the students' propensity for delay discounting? Is there a relationship between the level of delay discounting among students, their academic performance, and school attendance? Participants in the study, high school students enrolled in the "Pé-de-Meia" Program, will undergo assessments to measure their level of delay discounting. The academic performance and school attendance of the participants will be monitored and analyzed in relation to their propensity for delay discounting
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: PAMELA MIRANDA
- Phone Number: 65992112831
- Email: pamela.miranda@ifmt.edu.br
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
High school students, Students from public schools; Students from low-income families. -
Exclusion Criteria:
Students with a formal psychological report; students with a formal psychiatric report.
-
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Participants of the Pé-de-Meia Program
|
The "Pé-de-Meia" Program was established by the Brazilian Federal Government with the aim of encouraging the retention of low-income students in high school by providing maintenance scholarships and savings opportunities. To be eligible for the program, a young person must: Be properly enrolled in a regular public high school course, be between 14 to 24 years old, come from a low-income family, and be registered in the Bolsa Família Program. The Program offers four types of incentives: An enrollment grant registered at the beginning of the academic year, paid once a year in the amount of 200 BRL. A minimum school attendance of 80% of the total class hours, paid in nine installments throughout the year at 200 BRL each. Proven participation in the National High School Exam (ENEM), paid once to the student enrolled in the third year of high school, in the amount of 200 BRL. Completion of the high school academic years, paid in a single installment of 1,000 BRL. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Delay discounting
Time Frame: April 2024, July 2024, October 2024, December 2024, February 2025, April 2025, July 2025, October 2025, December 2025
|
Delay discounting measured by the Monetary Choice Questionnaire (MCQ).0.0 indicates an absence of discounting, meaning the individual values immediate and future rewards equally. This can be interpreted as a preference for delayed rewards or a long-term perspective. 0.5 indicates strong discounting, meaning the individual significantly devalues future rewards in favor of immediate ones. This is seen as an indication of high impulsivity. |
April 2024, July 2024, October 2024, December 2024, February 2025, April 2025, July 2025, October 2025, December 2025
|
|
Academic performance - grades
Time Frame: December 2024 and December 2025
|
Academic performance will be assessed based on school grades, categorized as follows: grades below 6 will indicate low performance; grades between 6 and 8 will reflect a medium performance; and grades between 8 and 10, a high performance
|
December 2024 and December 2025
|
|
School attendance
Time Frame: December 2024 and December 2025
|
School attendance will be evaluated based on the regularity of class attendance, organized into the following categories: an attendance rate below 80% will be considered low, while an attendance rate of 80% or more will indicate excellent school attendance.
|
December 2024 and December 2025
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- obs. Delay Discounting
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delay Discounting
-
University of KansasUniversity of Maryland, Baltimore; National Institute on Aging (NIA); University... and other collaboratorsRecruitingDelay DiscountingUnited States
-
Federal Institute of Education, Science and Technology...Not yet recruiting
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingNeurodevelopmental Delay
-
Tokat Gaziosmanpasa UniversityRecruiting
-
Florida Gulf Coast UniversityRecruitingDevelopmental DelayUnited States
-
Riphah International UniversityCompleted
-
Lawson Health Research InstituteAcademic Medical Organization of Southwestern OntarioCompleted
-
Taipei Medical UniversityNot yet recruiting
-
Riphah International UniversityCompletedDevelopment DelayPakistan
-
Hacettepe UniversityCompleted
Clinical Trials on Pé-de-Meia Program
-
VA Office of Research and DevelopmentVHA Pharmacy Benefits Management Services VA Center For Medication SafetyCompletedEvaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program (RaPPID)Proton Pump InhibitorsUnited States
-
Douglas Mental Health University InstituteActive, not recruitingSchizophrenia | Cognitive Impairment | PsychosisCanada
-
Iria GrandeRecruitingSuicide, Attempted | Cognition | Neuroimaging | Quality of Lifte | Functioning, PsychosocialSpain
-
University of ZurichWaid City Hospital, ZurichCompletedMild Cognitive Impairment | Mild Dementia | Fall PreventionSwitzerland
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)RecruitingCancer Education | Spanish Language Cancer EducationUnited States, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Metastatic Small Intestinal Adenocarcinoma | Stage IV Small Intestinal Adenocarcinoma AJCC v8United States
-
Yazeed SawalhaSuspendedDiffuse Large B-Cell Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise Specified | T-Cell/Histiocyte-Rich Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma UnclassifiableUnited States
-
M.D. Anderson Cancer CenterActive, not recruiting